15 Nov 2022

Build or Buy: What are The Key Considerations in Choosing the Right CDMO Partner?

In recent years, the standardization of biologics manufacturing processes has given product developers multiple viable options for producing biologics. These options include building an in-house production system or partnering with a contract biologics manufacturer. Although building in-house does offer the advantage of direct control; the time, labor, and spend required to implement this often makes it the inefficient choice. On the other hand, working with an experienced contract manufacturer can help you save time and costs by leveraging a deep pool of industry experience. However, the process of selecting the right CDMO partner needs to be performed after careful analysis of many factors: any of which, if overlooked, can create risk of delay or cost overrun. In this session, we will discuss the key parameters that you can easily assess when choosing the right innovative CDMO partner that will keep you competitive in a rapidly evolving market.

Content provided by our supplier

Samsung Biologics Co., Ltd.

  • KR
  • 2018
    On CPHI since
  • 4
  • 1000 - 4999
Company types
Biopharmaceutical company
Contract Service
Primary activities
Contract Manufacturer

Other Content from Samsung Biologics Co., Ltd. (22)